| 中文名 | 1-甲基-5-(4,4,5,5-四甲基-1,3,2-二硼戊环-2-基)-1H-苯并[d]咪唑 |
|---|---|
| 英文名 | 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole |
| 英文别名 |
1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole
1-Methyl-1H-benzimidazole-5-boronic acid pinacol ester |
| 沸点 | 400.8±37.0°C |
|---|---|
| 分子式 | C14H21BN2O3 |
| 分子量 | 276.13900 |
| 精确质量 | 276.16500 |
| PSA | 67.51000 |
| LogP | 0.82690 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | Xi |
|---|
|
~%
1107627-02-0 |
| 文献:TAKEDA PHARMACEUTICAL COMPANY LIMITED; LAWSON, John David; SABAT, Mark; SMITH, Christopher; WANG, Haixia; CHEN, Young K.; KANOUNI, Toufike Patent: WO2013/148603 A1, 2013 ; Location in patent: Paragraph 0219-0220 ; |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |